Jensen F S, Bartels C F, La Du B N
Department of Anaesthesia, Rigshospitalet, University of Copenhagen, Denmark.
Pharmacogenetics. 1992 Oct;2(5):234-40. doi: 10.1097/00008571-199210000-00006.
The rare H-variant of human butyrylcholinesterase is a quantitative variant that reduces serum butyrylcholinesterase activity by about 90%. Individuals who are heterozygous for both the H-variant and the atypical variant are abnormally sensitive to the muscle relaxant succinylcholine. By using standard phenotypic serum assays, the Danish Cholinesterase Research Unit identified four individuals from two unrelated pedigrees who were heterozygous for both the H-variant (H) and the atypical (A) variant. DNA of these A/H individuals was extracted from white blood cells. Using the polymerase chain reaction and subsequent DNA sequencing, a point mutation was found at nucleotide 424 which changed amino acid 142 from valine to methionine. The previously identified atypical mutation, Asp 70 to Gly, was also seen, which segregated apart from the H-variant mutation in family studies. These two mutations were found in all four A/H individuals.
人类丁酰胆碱酯酶的罕见H变异体是一种数量变异体,可使血清丁酰胆碱酯酶活性降低约90%。同时携带H变异体和非典型变异体的杂合子个体对肌肉松弛剂琥珀酰胆碱异常敏感。通过使用标准的表型血清检测方法,丹麦胆碱酯酶研究单位从两个无亲缘关系的家系中鉴定出4名个体,他们同时是H变异体(H)和非典型(A)变异体的杂合子。这些A/H个体的DNA从白细胞中提取。使用聚合酶链反应和随后的DNA测序,在核苷酸424处发现一个点突变,该突变使氨基酸142从缬氨酸变为甲硫氨酸。之前鉴定出的非典型突变,即天冬氨酸70变为甘氨酸,也被发现,在家族研究中,该突变与H变异体突变分离。在所有4名A/H个体中均发现了这两种突变。